Neuropsychiatric aspects of long COVID: A comprehensive review

Although some patients have persistent symptoms or develop new symptoms following coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID are not well known. This review summarizes and provides an update on the neuropsychiatric dimensions of long COVID. Its neuropsychia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychiatry and clinical neurosciences Jg. 77; H. 2; S. 84 - 93
Hauptverfasser: Kubota, Takafumi, Kuroda, Naoto, Sone, Daichi
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Melbourne John Wiley & Sons Australia, Ltd 01.02.2023
Wiley Subscription Services, Inc
Schlagworte:
Anxiety Disorders
Cognitive ability
Coronaviruses
COVID-19
Drug therapy
Environmental changes
Humans
Infections
Ischemia
Long COVID
Medical treatment
Mental disorders
neurology
PCN Frontier Review
PCN Frontier Reviews
Positron emission tomography
post COVID‐19 condition
Post-Acute COVID-19 Syndrome
psychiatry
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Sleep disorders
Vaccination
COVID-19
long COVID
psychiatry
post COVID-19 condition
neurology
ISSN:1323-1316, 1440-1819, 1440-1819
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Although some patients have persistent symptoms or develop new symptoms following coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID are not well known. This review summarizes and provides an update on the neuropsychiatric dimensions of long COVID. Its neuropsychiatric manifestations commonly include fatigue, cognitive impairment, sleep disorders, depression, anxiety, and post‐traumatic stress disorder. There are no specific tests for long COVID, but some characteristic findings such as hypometabolism on positron emission tomography have been reported. The possible mechanisms of long COVID include inflammation, ischemic effects, direct viral invasion, and social and environmental changes. Some patient characteristics and the severity and complications of acute COVID‐19 infection may be associated with an increased risk of neuropsychiatric symptoms. Long COVID may resolve spontaneously or persist, depending on the type of neuropsychiatric symptoms. Although established treatments are lacking, various psychological and pharmacological treatments have been attempted. Vaccination against COVID‐19 infection plays a key role in the prevention of long coronavirus disease. With differences among the SARS‐CoV‐2 variants, including the omicron variant, the aspects of long COVID are likely to change in the future. Further studies clarifying the aspects of long COVID to develop effective treatments are warranted. Overview of neuropsychiatric aspects of long COVID.
AbstractList Although some patients have persistent symptoms or develop new symptoms following coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID are not well known. This review summarizes and provides an update on the neuropsychiatric dimensions of long COVID. Its neuropsychiatric manifestations commonly include fatigue, cognitive impairment, sleep disorders, depression, anxiety, and post‐traumatic stress disorder. There are no specific tests for long COVID, but some characteristic findings such as hypometabolism on positron emission tomography have been reported. The possible mechanisms of long COVID include inflammation, ischemic effects, direct viral invasion, and social and environmental changes. Some patient characteristics and the severity and complications of acute COVID‐19 infection may be associated with an increased risk of neuropsychiatric symptoms. Long COVID may resolve spontaneously or persist, depending on the type of neuropsychiatric symptoms. Although established treatments are lacking, various psychological and pharmacological treatments have been attempted. Vaccination against COVID‐19 infection plays a key role in the prevention of long coronavirus disease. With differences among the SARS‐CoV‐2 variants, including the omicron variant, the aspects of long COVID are likely to change in the future. Further studies clarifying the aspects of long COVID to develop effective treatments are warranted.
Although some patients have persistent symptoms or develop new symptoms following coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID are not well known. This review summarizes and provides an update on the neuropsychiatric dimensions of long COVID. Its neuropsychiatric manifestations commonly include fatigue, cognitive impairment, sleep disorders, depression, anxiety, and post‐traumatic stress disorder. There are no specific tests for long COVID, but some characteristic findings such as hypometabolism on positron emission tomography have been reported. The possible mechanisms of long COVID include inflammation, ischemic effects, direct viral invasion, and social and environmental changes. Some patient characteristics and the severity and complications of acute COVID‐19 infection may be associated with an increased risk of neuropsychiatric symptoms. Long COVID may resolve spontaneously or persist, depending on the type of neuropsychiatric symptoms. Although established treatments are lacking, various psychological and pharmacological treatments have been attempted. Vaccination against COVID‐19 infection plays a key role in the prevention of long coronavirus disease. With differences among the SARS‐CoV‐2 variants, including the omicron variant, the aspects of long COVID are likely to change in the future. Further studies clarifying the aspects of long COVID to develop effective treatments are warranted. Overview of neuropsychiatric aspects of long COVID.
Although some patients have persistent symptoms or develop new symptoms following coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID are not well known. This review summarizes and provides an update on the neuropsychiatric dimensions of long COVID. Its neuropsychiatric manifestations commonly include fatigue, cognitive impairment, sleep disorders, depression, anxiety, and post‐traumatic stress disorder. There are no specific tests for long COVID, but some characteristic findings such as hypometabolism on positron emission tomography have been reported. The possible mechanisms of long COVID include inflammation, ischemic effects, direct viral invasion, and social and environmental changes. Some patient characteristics and the severity and complications of acute COVID‐19 infection may be associated with an increased risk of neuropsychiatric symptoms. Long COVID may resolve spontaneously or persist, depending on the type of neuropsychiatric symptoms. Although established treatments are lacking, various psychological and pharmacological treatments have been attempted. Vaccination against COVID‐19 infection plays a key role in the prevention of long coronavirus disease. With differences among the SARS‐CoV‐2 variants, including the omicron variant, the aspects of long COVID are likely to change in the future. Further studies clarifying the aspects of long COVID to develop effective treatments are warranted. Overview of neuropsychiatric aspects of long COVID.
Although some patients have persistent symptoms or develop new symptoms following coronavirus disease 2019 (COVID-19) infection, neuropsychiatric aspects of long COVID are not well known. This review summarizes and provides an update on the neuropsychiatric dimensions of long COVID. Its neuropsychiatric manifestations commonly include fatigue, cognitive impairment, sleep disorders, depression, anxiety, and post-traumatic stress disorder. There are no specific tests for long COVID, but some characteristic findings such as hypometabolism on positron emission tomography have been reported. The possible mechanisms of long COVID include inflammation, ischemic effects, direct viral invasion, and social and environmental changes. Some patient characteristics and the severity and complications of acute COVID-19 infection may be associated with an increased risk of neuropsychiatric symptoms. Long COVID may resolve spontaneously or persist, depending on the type of neuropsychiatric symptoms. Although established treatments are lacking, various psychological and pharmacological treatments have been attempted. Vaccination against COVID-19 infection plays a key role in the prevention of long coronavirus disease. With differences among the SARS-CoV-2 variants, including the omicron variant, the aspects of long COVID are likely to change in the future. Further studies clarifying the aspects of long COVID to develop effective treatments are warranted.Although some patients have persistent symptoms or develop new symptoms following coronavirus disease 2019 (COVID-19) infection, neuropsychiatric aspects of long COVID are not well known. This review summarizes and provides an update on the neuropsychiatric dimensions of long COVID. Its neuropsychiatric manifestations commonly include fatigue, cognitive impairment, sleep disorders, depression, anxiety, and post-traumatic stress disorder. There are no specific tests for long COVID, but some characteristic findings such as hypometabolism on positron emission tomography have been reported. The possible mechanisms of long COVID include inflammation, ischemic effects, direct viral invasion, and social and environmental changes. Some patient characteristics and the severity and complications of acute COVID-19 infection may be associated with an increased risk of neuropsychiatric symptoms. Long COVID may resolve spontaneously or persist, depending on the type of neuropsychiatric symptoms. Although established treatments are lacking, various psychological and pharmacological treatments have been attempted. Vaccination against COVID-19 infection plays a key role in the prevention of long coronavirus disease. With differences among the SARS-CoV-2 variants, including the omicron variant, the aspects of long COVID are likely to change in the future. Further studies clarifying the aspects of long COVID to develop effective treatments are warranted.
Author Kuroda, Naoto
Kubota, Takafumi
Sone, Daichi
AuthorAffiliation 3 Department of Epileptology Tohoku University Graduate School of Medicine Sendai Japan
2 Department of Neurology Tohoku University Graduate School of Medicine Sendai Japan
1 Department of Neurology National Hospital Organization Sendai Medical Center Sendai Japan
5 Department of Psychiatry Jikei University School of Medicine Tokyo Japan
4 Department of Pediatrics Wayne State University Detroit Michigan USA
AuthorAffiliation_xml – name: 5 Department of Psychiatry Jikei University School of Medicine Tokyo Japan
– name: 3 Department of Epileptology Tohoku University Graduate School of Medicine Sendai Japan
– name: 2 Department of Neurology Tohoku University Graduate School of Medicine Sendai Japan
– name: 1 Department of Neurology National Hospital Organization Sendai Medical Center Sendai Japan
– name: 4 Department of Pediatrics Wayne State University Detroit Michigan USA
Author_xml – sequence: 1
  givenname: Takafumi
  orcidid: 0000-0003-3632-9679
  surname: Kubota
  fullname: Kubota, Takafumi
  email: takafumi.kubota.0612@gmail.com
  organization: Tohoku University Graduate School of Medicine
– sequence: 2
  givenname: Naoto
  surname: Kuroda
  fullname: Kuroda, Naoto
  organization: Wayne State University
– sequence: 3
  givenname: Daichi
  orcidid: 0000-0001-9617-706X
  surname: Sone
  fullname: Sone, Daichi
  organization: Jikei University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36385449$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9P3DAQxa0KVP60h36BKlIv7SHgiR3b6aEVWqAgIegB9Wo53glrlLVTO1m0375elqIWqfXFluY3b974HZAdHzwS8g7oEeRzPFh_BKym6hXZB85pCQqanfxmFSuBgdgjByndU0oZE_Ca7DHBVM15s0--XOMUw5DWduHMGJ0tTBrQjqkIXdEHf1fMbn5cnn4uTgoblkPEBfrkVlhEXDl8eEN2O9MnfPt0H5Lb87Pb2UV5dfPtcnZyVdqacVW2cxQIaBjtVAsdVExKTs28ZkYJZQS0QkkJDRhqlLWG17JpBMiOdrStanZIvm5lh6ld4tyiH6Pp9RDd0sS1DsbpvyveLfRdWGmgQBXUIit8fFKI4eeEadRLlyz2vfEYpqQrySQXQrHNsA8v0PswRZ_Xy5RkdcUl8Ey9_9PSs5ffX5uBT1vAxpBSxO4ZAao3sekcm36MLbPHL1jrRjO6sNnG9f_reHA9rv8trb_PrrcdvwBqs6dH
CitedBy_id crossref_primary_10_1016_j_actpsy_2025_104935
crossref_primary_10_7759_cureus_55089
crossref_primary_10_1016_j_aprim_2024_103214
crossref_primary_10_3390_antiox12111942
crossref_primary_10_1007_s00406_023_01661_3
crossref_primary_10_3389_fphar_2025_1588037
crossref_primary_10_1007_s11606_024_09062_5
crossref_primary_10_1097_MS9_0000000000003066
crossref_primary_10_1016_j_bbi_2023_11_028
crossref_primary_10_1016_j_euroneuro_2023_11_001
crossref_primary_10_1002_pmrj_13085
crossref_primary_10_1093_biomethods_bpad038
crossref_primary_10_1016_j_jad_2024_08_214
crossref_primary_10_1080_21641846_2023_2286028
crossref_primary_10_1111_cob_12708
crossref_primary_10_1080_02791072_2025_2478097
crossref_primary_10_1007_s11910_023_01286_y
crossref_primary_10_1016_j_jaclp_2023_12_005
crossref_primary_10_1038_s41598_023_33326_5
crossref_primary_10_1080_14740338_2025_2471509
crossref_primary_10_1111_pcn_13716
crossref_primary_10_3389_fimmu_2025_1624011
crossref_primary_10_3389_fpsyt_2025_1555370
crossref_primary_10_1590_1413_81232025304_14312024
crossref_primary_10_3390_microorganisms12050909
crossref_primary_10_1002_pcn5_70190
crossref_primary_10_1080_13548506_2024_2439180
crossref_primary_10_3389_fimmu_2025_1515768
crossref_primary_10_3389_fneur_2024_1334161
crossref_primary_10_1097_IN9_0000000000000068
crossref_primary_10_1002_npr2_12495
crossref_primary_10_1016_j_neuroimage_2024_120859
crossref_primary_10_3233_ADR_230172
crossref_primary_10_7717_peerj_16669
crossref_primary_10_1002_pcn5_70146
crossref_primary_10_1007_s13206_025_00226_x
crossref_primary_10_1016_j_outlook_2024_102341
crossref_primary_10_3389_fped_2023_1165072
crossref_primary_10_3390_life15030439
crossref_primary_10_1097_MS9_0000000000001624
crossref_primary_10_3390_diseases12050095
crossref_primary_10_1016_j_jad_2025_05_018
crossref_primary_10_1111_ijn_13202
crossref_primary_10_7717_peerj_19575
crossref_primary_10_1038_s41392_023_01640_z
crossref_primary_10_1186_s12967_025_06535_x
crossref_primary_10_2188_jea_JE20230360
crossref_primary_10_1007_s00705_023_05801_x
crossref_primary_10_1016_j_jpsychores_2023_111535
crossref_primary_10_3390_v16121811
crossref_primary_10_3390_brainsci15080800
crossref_primary_10_3390_brainsci13121666
crossref_primary_10_3947_ic_2024_0090
crossref_primary_10_1016_j_msard_2023_105120
crossref_primary_10_1186_s12888_023_05481_6
crossref_primary_10_1016_j_neuroscience_2025_07_038
crossref_primary_10_3389_fmed_2024_1399145
crossref_primary_10_1080_00223980_2024_2437382
crossref_primary_10_1186_s12889_023_16524_8
crossref_primary_10_1016_j_dscb_2023_100074
crossref_primary_10_1093_sleepadvances_zpaf051
crossref_primary_10_1097_MD_0000000000042891
crossref_primary_10_1097_PR9_0000000000001287
crossref_primary_10_1016_j_humimm_2024_110795
crossref_primary_10_1016_j_lfs_2024_122977
crossref_primary_10_1038_s41598_024_73311_0
crossref_primary_10_1080_14737175_2024_2440543
crossref_primary_10_1177_20503121231194400
crossref_primary_10_1002_pcn5_223
crossref_primary_10_1080_21645515_2025_2551930
crossref_primary_10_7759_cureus_88680
crossref_primary_10_3390_jcm12124013
crossref_primary_10_1155_da_5727506
crossref_primary_10_1186_s41983_025_00972_7
crossref_primary_10_3390_s24041250
crossref_primary_10_1159_000545349
crossref_primary_10_1093_nutrit_nuaf141
crossref_primary_10_3389_fneur_2025_1547893
crossref_primary_10_1186_s12967_023_04588_4
crossref_primary_10_1097_JCP_0000000000002087
crossref_primary_10_1002_alz_70079
crossref_primary_10_1016_j_euroneuro_2024_12_014
Cites_doi 10.1111/ene.15324
10.1007/s00431-021-04345-z
10.1016/S2215-0366(20)30462-4
10.1097/PHM.0000000000001910
10.1038/s41591-022-01840-0
10.1007/s00415-021-10655-x
10.1016/j.psyneuen.2021.105295
10.1186/s40478-021-01302-7
10.1016/j.eclinm.2021.101019
10.2967/jnumed.121.262128
10.1093/ofid/ofab384
10.1016/j.jpsychires.2021.09.054
10.4103/0972-6748.328787
10.1007/s40520-021-02042-3
10.1177/03331024211020404
10.1016/j.psychres.2021.114243
10.1186/s12879-022-07052-8
10.1038/s41586-020-2247-3
10.1007/s10072-021-05786-y
10.1016/j.psychres.2022.114427
10.1016/j.yebeh.2021.108361
10.1111/cea.13997
10.3389/fpsyt.2021.765106
10.1093/braincomms/fcaa205
10.1042/BCJ20220016
10.1001/jamaneurol.2020.1127
10.1093/braincomms/fcab297
10.2967/jnumed.121.263085
10.1016/S0140-6736(20)32656-8
10.1007/s10072-021-05630-3
10.1038/s41371-022-00660-6
10.1017/cjn.2021.256
10.1111/ene.15307
10.1007/s00415-022-11047-5
10.1016/j.ajp.2021.102815
10.1016/j.yebeh.2020.107682
10.3389/fnhum.2021.678472
10.1001/jama.2022.11691
10.1007/s11606-021-07242-1
10.1101/2021.04.15.21255348
10.1007/s11356-021-18384-4
10.1002/mds.28084
10.1177/14799731211015691
10.1212/WNL.0000000000200356
10.1007/s00259-021-05528-4
10.1016/j.yebeh.2021.107852
10.1016/j.bbi.2020.03.031
10.1007/s15010-021-01733-3
10.3390/brainsci12020265
10.1016/S2215-0366(21)00084-5
10.1111/ijcp.14917
10.1017/S003329172200006X
10.2196/33704
10.1007/s00259-021-05342-y
10.1093/arclin/acac004
10.1016/j.bbi.2021.12.020
10.1016/j.genhosppsych.2022.01.002
10.1136/jim-2021-002051
10.1080/20008198.2021.1959707
10.3390/jcm11061541
10.1016/j.neurad.2022.03.003
10.1186/s12877-015-0103-3
10.1097/CCM.0000000000005476
10.3390/jpm11111203
10.1016/j.jns.2022.120146
10.1080/03007995.2022.2042991
10.1016/j.bbi.2020.05.048
10.3390/ph15030345
10.1177/20499361211048572
10.1007/s11920-021-01237-9
10.1111/ene.15215
10.3389/fpsyt.2021.725861
10.1002/brb3.2508
10.1016/S2215-0366(22)00260-7
10.3390/ijerph19042290
10.1056/NEJMoa2002032
10.1007/s00259-021-05215-4
10.1037/ser0000630
10.1101/2022.01.07.475453
10.1016/S1474-4422(20)30308-2
10.1097/XCE.0000000000000253
10.1016/j.euroneuro.2021.03.019
10.3390/jcm10194337
10.1016/j.stem.2020.12.018
10.1007/s00259-021-05294-3
10.1002/jmv.27397
10.1093/braincomms/fcab295
10.1007/s13760-021-01790-3
10.1002/ana.26262
10.3389/fpsyg.2022.770459
10.1016/j.jns.2020.117271
10.1111/pcn.13168
10.1016/j.bbi.2021.07.018
10.1093/braincomms/fcac206
10.1016/j.jinf.2022.02.003
10.1002/prp2.911
10.1016/j.bbih.2021.100347
10.1016/j.psychres.2020.113312
10.1016/S0140-6736(21)01755-4
10.2967/jnumed.121.262677
10.1002/acn3.51496
10.1080/13854046.2022.2030412
10.1002/alz.12644
10.1183/13993003.04364-2020
10.1212/NXI.0000000000001080
10.1016/S2213-2600(21)00031-X
10.1038/s41598-021-95565-8
10.1177/03331024211068074
10.1007/s13139-021-00730-6
10.1007/s40521-021-00297-9
10.1007/s00259-022-05753-5
10.1016/j.bbih.2021.100387
10.1016/j.amjoto.2020.102884
10.1016/S0140-6736(22)00941-2
10.1007/s00408-009-9176-0
ContentType Journal Article
Copyright 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
2022 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
– notice: 2022 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
– notice: 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
7X8
5PM
DOI 10.1111/pcn.13508
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)


CrossRef
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Neuropsychiatric aspects of long COVID
EISSN 1440-1819
EndPage 93
ExternalDocumentID PMC10108156
36385449
10_1111_pcn_13508
PCN13508
Genre miscellaneous
Journal Article
Review
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
24P
29P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
7.U
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIVO
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPS
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TKC
TR2
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZXP
ZZTAW
~02
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
7X8
5PM
ID FETCH-LOGICAL-c5348-bde6e1ea30f8b1f1237740ad53a868a61b6877191a0a8cca45799617f0f0b253
IEDL.DBID 24P
ISICitedReferencesCount 90
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000896704600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1323-1316
1440-1819
IngestDate Tue Sep 30 17:15:09 EDT 2025
Sun Nov 09 12:37:14 EST 2025
Sat Nov 29 14:28:50 EST 2025
Wed Feb 19 02:25:04 EST 2025
Sat Nov 29 06:00:02 EST 2025
Tue Nov 18 21:43:04 EST 2025
Wed Jan 22 16:17:05 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords COVID-19
long COVID
psychiatry
post COVID-19 condition
neurology
Language English
License Attribution
2022 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5348-bde6e1ea30f8b1f1237740ad53a868a61b6877191a0a8cca45799617f0f0b253
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0001-9617-706X
0000-0003-3632-9679
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpcn.13508
PMID 36385449
PQID 2773524714
PQPubID 1106347
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10108156
proquest_miscellaneous_2737466835
proquest_journals_2773524714
pubmed_primary_36385449
crossref_primary_10_1111_pcn_13508
crossref_citationtrail_10_1111_pcn_13508
wiley_primary_10_1111_pcn_13508_PCN13508
PublicationCentury 2000
PublicationDate February 2023
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: February 2023
PublicationDecade 2020
PublicationPlace Melbourne
PublicationPlace_xml – name: Melbourne
– name: Australia
– name: Tokyo
PublicationTitle Psychiatry and clinical neurosciences
PublicationTitleAlternate Psychiatry Clin Neurosci
PublicationYear 2023
Publisher John Wiley & Sons Australia, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons Australia, Ltd
– name: Wiley Subscription Services, Inc
References 2021; 64
2021; 23
2022; 70
2021; 125
2021; 28
2010; 188
2022; 63
2020; 56
2022; 20
2022; 22
2021; 30
2022; 28
2022; 29
2020; 19
2022; 122
2021; 38
2021; 75
2020; 2
2021; 398
2022; 84
2021; 117
2020; 292
2022; 34
2022; 36
2022; 37
2022; 75
2020; 89
2021; 397
2020; 87
2021; 83
2022; 328
2021; 41
2022; 38
2021; 9
2021; 8
2021; 46
2015; 15
2021; 48
2021; 4
2021; 42
2021; 2
2020; 581
2020; 382
2021; 420
2022; 50
2022; 94
2021; 305
2022; 91
2020; 35
2022; 42
2020; 77
2021; 144
2022; 43
2022; 00
2022; 438
2021; 51
2022; 49
2022; 479
2022; 399
2022; 101
2021; 57
2021; 13
2021; 15
2021; 10
2021; 97
2021; 12
2021; 11
2022
2022; 4
2022; 181
2021
2021; 18
2021; 17
2022; 9
2022; 12
2020; 115
2022; 56
2022; 13
2022; 15
2021; 131
2022; 10
2022; 99
2022; 2
2022; 11
2022; 309
2021; 62
2022; 269
2022; 18
2022; 19
e_1_2_13_120_1
e_1_2_13_24_1
e_1_2_13_47_1
e_1_2_13_20_1
e_1_2_13_66_1
e_1_2_13_101_1
e_1_2_13_43_1
e_1_2_13_124_1
e_1_2_13_85_1
e_1_2_13_8_1
e_1_2_13_62_1
e_1_2_13_81_1
e_1_2_13_92_1
e_1_2_13_96_1
e_1_2_13_117_1
e_1_2_13_17_1
e_1_2_13_13_1
e_1_2_13_36_1
e_1_2_13_131_1
e_1_2_13_32_1
e_1_2_13_55_1
e_1_2_13_78_1
e_1_2_13_112_1
e_1_2_13_135_1
e_1_2_13_51_1
e_1_2_13_74_1
e_1_2_13_70_1
e_1_2_13_4_1
e_1_2_13_105_1
e_1_2_13_88_1
e_1_2_13_109_1
e_1_2_13_48_1
e_1_2_13_100_1
e_1_2_13_21_1
e_1_2_13_67_1
e_1_2_13_104_1
e_1_2_13_123_1
e_1_2_13_86_1
e_1_2_13_9_1
e_1_2_13_40_1
e_1_2_13_63_1
e_1_2_13_82_1
e_1_2_13_91_1
e_1_2_13_116_1
e_1_2_13_99_1
e_1_2_13_18_1
Ferrando SJ (e_1_2_13_53_1) 2022; 63
e_1_2_13_14_1
e_1_2_13_111_1
e_1_2_13_130_1
e_1_2_13_37_1
e_1_2_13_79_1
e_1_2_13_10_1
e_1_2_13_56_1
e_1_2_13_115_1
e_1_2_13_134_1
e_1_2_13_33_1
e_1_2_13_75_1
e_1_2_13_52_1
Fernández‐de‐las‐Peñas C (e_1_2_13_25_1) 2021; 83
e_1_2_13_71_1
e_1_2_13_5_1
e_1_2_13_108_1
e_1_2_13_127_1
e_1_2_13_49_1
e_1_2_13_122_1
e_1_2_13_26_1
e_1_2_13_68_1
e_1_2_13_45_1
Sun B (e_1_2_13_95_1) 2021; 10
e_1_2_13_126_1
e_1_2_13_87_1
e_1_2_13_22_1
e_1_2_13_64_1
e_1_2_13_103_1
e_1_2_13_41_1
e_1_2_13_60_1
e_1_2_13_83_1
e_1_2_13_6_1
Thye AYK (e_1_2_13_89_1) 2022; 11
e_1_2_13_90_1
e_1_2_13_94_1
e_1_2_13_98_1
e_1_2_13_119_1
e_1_2_13_138_1
e_1_2_13_19_1
e_1_2_13_133_1
e_1_2_13_15_1
e_1_2_13_38_1
e_1_2_13_57_1
e_1_2_13_110_1
e_1_2_13_137_1
e_1_2_13_11_1
e_1_2_13_34_1
e_1_2_13_76_1
e_1_2_13_114_1
e_1_2_13_30_1
e_1_2_13_72_1
e_1_2_13_2_1
e_1_2_13_107_1
e_1_2_13_121_1
e_1_2_13_27_1
e_1_2_13_46_1
e_1_2_13_69_1
e_1_2_13_102_1
e_1_2_13_125_1
e_1_2_13_23_1
e_1_2_13_42_1
e_1_2_13_65_1
Giurgi‐oncu C (e_1_2_13_59_1) 2021; 2
e_1_2_13_84_1
e_1_2_13_7_1
e_1_2_13_61_1
e_1_2_13_80_1
e_1_2_13_93_1
e_1_2_13_97_1
e_1_2_13_118_1
e_1_2_13_39_1
e_1_2_13_132_1
e_1_2_13_35_1
e_1_2_13_16_1
e_1_2_13_58_1
e_1_2_13_113_1
e_1_2_13_136_1
e_1_2_13_31_1
e_1_2_13_77_1
e_1_2_13_12_1
e_1_2_13_54_1
Webster KE (e_1_2_13_128_1) 2022; 9
e_1_2_13_73_1
e_1_2_13_50_1
Ferri S (e_1_2_13_29_1) 2020; 56
e_1_2_13_3_1
e_1_2_13_106_1
e_1_2_13_129_1
e_1_2_13_28_1
Izquierdo MR (e_1_2_13_44_1) 2022; 20
References_xml – volume: 12
  start-page: 1
  year: 2021
  end-page: 7
  article-title: Association between psychological distress, cognitive complaints, and neuropsychological status after a severe COVID‐19 episode: A cross‐sectional study
  publication-title: Front. Psychiatry
– volume: 115
  year: 2020
  article-title: Meta‐analysis of EEG findings in patients with COVID‐19
  publication-title: Epilepsy Behav.
– volume: 48
  start-page: 2674
  year: 2021
  end-page: 2675
  article-title: About the source and consequences of F‐FDG brain PET hypometabolism in short and long COVID‐19
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
– volume: 87
  start-page: 18
  year: 2020
  end-page: 22
  article-title: Nervous system involvement after infection with COVID‐19 and other coronaviruses
  publication-title: Brain. Behav. Immun.
– volume: 94
  start-page: 971
  year: 2022
  end-page: 978
  article-title: Persistence of sleep disturbance among post‐COVID patients: Findings from a 2‐month follow‐up study in a Bangladeshi cohort
  publication-title: J. Med. Virol.
– start-page: 1
  end-page: 12
– volume: 8
  start-page: 130
  year: 2021
  end-page: 140
  article-title: Bidirectional associations between COVID‐19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID‐19 cases in the USA
  publication-title: Lancet Psychiatry
– volume: 8
  start-page: 1
  year: 2021
  end-page: 8
  article-title: Long‐term coronavirus disease 2019 complications in inpatients and outpatients: A one‐year follow‐up cohort study
  publication-title: Open Forum Infect. Dis.
– volume: 292
  year: 2020
  article-title: PTSD symptoms in healthcare workers facing the three coronavirus outbreaks: What can we expect after the COVID‐19 pandemic
  publication-title: Psychiatry Res.
– volume: 15
  year: 2021
  article-title: Previous history of migraine is associated with fatigue, but not headache, as long‐term post‐COVID symptom after severe acute respiratory SARS‐CoV‐2 infection: A case–control study
  publication-title: Front. Hum. Neurosci.
– volume: 36
  start-page: 806
  year: 2022
  end-page: 828
  article-title: Outcomes in post‐acute sequelae of COVID‐19 (PASC) at 6 months post‐infection part 1: Cognitive functioning
  publication-title: Clin. Neuropsychol.
– volume: 10
  start-page: 193
  year: 2021
  end-page: 203
  article-title: The microvascular hypothesis underlying neurologic manifestations of long COVID‐19 and possible therapeutic strategies
  publication-title: Cardiovasc. Endocrinol. Metab.
– volume: 56
  start-page: 2372
  year: 2020
  article-title: Impact of cough on insomnia and sleep quality in bronchiectasis
  publication-title: Eur. Respir. J.
– volume: 12
  start-page: 1
  year: 2022
  end-page: 11
  article-title: Neuropsychological deficits in patients with cognitive complaints after COVID‐19
  publication-title: Brain Behav.
– volume: 101
  start-page: 93
  year: 2022
  end-page: 135
  article-title: Fatigue and cognitive impairment in post‐COVID‐19 syndrome: A systematic review and meta‐analysis
  publication-title: Brain Behav. Immun.
– volume: 9
  start-page: 1
  year: 2021
  end-page: 13
  article-title: APOE ε4 associates with increased risk of severe COVID‐19, cerebral microhaemorrhages and post‐COVID mental fatigue: A Finnish biobank, autopsy and clinical study
  publication-title: Acta Neuropathol. Commun.
– volume: 48
  start-page: 2823
  year: 2021
  end-page: 2833
  article-title: 18F‐FDG brain PET hypometabolism in patients with long COVID
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
– volume: 00
  start-page: 1
  year: 2022
  end-page: 9
– year: 2022
– volume: 70
  start-page: 61
  year: 2022
  end-page: 67
  article-title: Long COVID following mild SARS‐CoV‐2 infection: Characteristic T cell alterations and response to antihistamines
  publication-title: J. Invest. Med.
– volume: 188
  start-page: 91
  year: 2010
  end-page: 94
  article-title: Cough and sleep
  publication-title: Lung
– volume: 43
  start-page: 2231
  year: 2022
  end-page: 2239
  article-title: Chronic fatigue syndrome and cognitive deficit are associated with acute‐phase neuropsychiatric manifestations of COVID‐19: A 9‐month follow‐up study
  publication-title: Neurol. Sci.
– volume: 2
  start-page: 1
  year: 2020
  end-page: 9
  article-title: Frequent neurocognitive deficits after recovery from mild COVID‐19
  publication-title: Brain Commun.
– volume: 13
  start-page: 1
  year: 2022
  end-page: 5
  article-title: Anticipating PTSD in severe COVID survivors: The case for screen‐and‐treat
  publication-title: Eur. J. Psychotraumatol.
– volume: 438
  year: 2022
  article-title: Demographic and social determinants of cognitive dysfunction following hospitalization for COVID‐19
  publication-title: J. Neurol. Sci.
– volume: 399
  start-page: 2263
  year: 2022
  end-page: 2264
  article-title: Risk of long COVID associated with delta versus omicron variants of SARS‐CoV‐2
  publication-title: Lancet
– start-page: 1
  year: 2022
  end-page: 21
– volume: 41
  start-page: 1332
  year: 2021
  end-page: 1341
  article-title: The presence of headache at onset in SARS‐CoV‐2 infection is associated with long‐term post‐COVID headache and fatigue: A case–control study
  publication-title: Cephalalgia
– volume: 382
  start-page: 1708
  year: 2020
  end-page: 1720
  article-title: Clinical characteristics of coronavirus disease 2019 in China
  publication-title: N. Engl. J. Med.
– volume: 10
  start-page: 1
  year: 2021
  end-page: 18
  article-title: Characterization and biomarker analyses of post‐COVID‐19 complications and neurological manifestations
  publication-title: Cell
– volume: 9
  year: 2022
  article-title: Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction
  publication-title: Cochrane Database Syst. Rev.
– volume: 11
  start-page: 1541
  year: 2022
  article-title: Prognostic factors for post‐COVID‐19 syndrome: A systematic review and meta‐analysis
  publication-title: J. Clin. Med.
– volume: 75
  year: 2021
  article-title: Obesity is associated with a greater number of long‐term post‐COVID symptoms and poor sleep quality: A multicentre case–control study
  publication-title: Int. J. Clin. Pract.
– volume: 13
  start-page: 1
  year: 2021
  end-page: 3
  article-title: Combined central and peripheral demyelination with anti‐neurofascin155 IgG following COVID‐19 vaccination
  publication-title: Can. J. Neurol. Sci.
– volume: 581
  start-page: 71
  year: 2020
  end-page: 76
  article-title: APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
  publication-title: Nature
– volume: 15
  year: 2022
  article-title: Efficacy of adaptogens in patients with long COVID‐19: A randomized, quadruple‐blind, placebo‐controlled trial
  publication-title: Pharmaceuticals (Basel)
– volume: 38
  start-page: 901
  year: 2022
  end-page: 909
  article-title: Post‐COVID‐19 syndrome, low‐grade inflammation and inflammatory markers: A cross‐sectional study
  publication-title: Curr. Med. Res. Opin.
– volume: 10
  start-page: 1
  year: 2022
  end-page: 10
  article-title: “LONG COVID” – A hypothesis for understanding the biological basis and pharmacological treatment strategy
  publication-title: Pharmacol. Res. Perspect.
– volume: 29
  start-page: 1685
  year: 2022
  end-page: 1696
  article-title: Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study
  publication-title: Eur. J. Neurol.
– volume: 9
  start-page: 1
  year: 2022
  end-page: 13
  article-title: The impact of long COVID‐19 on mental health: Observational 6‐month follow‐up study
  publication-title: JMIR Ment. Health
– volume: 97
  start-page: 328
  year: 2021
  end-page: 348
  article-title: Psychiatric and neuropsychiatric sequelae of COVID‐19 – A systematic review
  publication-title: Brain Behav. Immun.
– volume: 99
  year: 2022
  article-title: Trajectories of neurologic recovery 12 months after hospitalization for COVID‐19: A prospective longitudinal study
  publication-title: Neurology
– volume: 43
  start-page: 81
  year: 2022
  end-page: 84
  article-title: Screening for cognitive sequelae of SARS‐CoV‐2 infection: A comparison between the Mini‐Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA)
  publication-title: Neurol. Sci.
– volume: 50
  start-page: 945
  year: 2022
  end-page: 954
  article-title: Sleep and circadian health of critical COVID‐19 survivors 3 months after hospital discharge
  publication-title: Crit. Care Med.
– volume: 13
  start-page: 770459
  year: 2022
  article-title: Cognitive impairment in non‐critical, mild‐to‐moderate COVID‐19 survivors
  publication-title: Front. Psychol.
– volume: 8
  year: 2021
– volume: 420
  year: 2021
  article-title: Neuropsychological and neurophysiological correlates of fatigue in post‐acute patients with neurological manifestations of COVID‐19: Insights into a challenging symptom
  publication-title: J. Neurol. Sci.
– volume: 269
  start-page: 44
  year: 2022
  end-page: 46
  article-title: Long COVID: Cognitive complaints (brain fog) and dysfunction of the cingulate cortex
  publication-title: J. Neurol.
– volume: 63
  start-page: 474
  year: 2022
  end-page: 548
  article-title: Neuropsychological, medical, and psychiatric findings after recovery from acute COVID‐19: A cross‐sectional study
  publication-title: J. Acad. Consult. Psychiatry
– volume: 17
  year: 2021
  article-title: Post‐acute sequelae of COVID‐19: Evidence of mood & cognitive impairment
  publication-title: Brain Behav. Immun. Health
– volume: 75
  start-page: 38
  year: 2022
  end-page: 45
  article-title: Post‐COVID‐19 psychiatric and cognitive morbidity: Preliminary findings from a Brazilian cohort study
  publication-title: Gen. Hosp. Psychiatry
– volume: 101
  start-page: 48
  year: 2022
  end-page: 52
  article-title: Post‐acute COVID‐19 syndrome negatively impacts physical function, cognitive function, health‐related quality of life, and participation
  publication-title: Am. J. Phys. Med. Rehabil.
– volume: 49
  start-page: 329
  year: 2022
  end-page: 332
  article-title: Transient modifications of the olfactory bulb on MR follow‐up of COVID‐19 patients with related olfactory dysfunction
  publication-title: J. Neuroradiol.
– volume: 29
  start-page: 28062
  year: 2022
  end-page: 28069
  article-title: Circadian rhythm disorder and anxiety as mental health complications in post‐COVID‐19
  publication-title: Environ. Sci. Pollut. Res.
– volume: 42
  start-page: 102884
  year: 2021
  article-title: Corticosteroid nasal spray for recovery of smell sensation in COVID‐19 patients: A randomized controlled trial
  publication-title: Am. J. Otolaryngol.
– volume: 35
  start-page: 716
  year: 2020
  end-page: 720
  article-title: SARS‐CoV‐2: At the crossroad between aging and neurodegeneration
  publication-title: Mov. Disord.
– volume: 34
  start-page: 257
  year: 2022
  end-page: 260
  article-title: Premorbid vulnerability and disease severity impact on long‐COVID cognitive impairment
  publication-title: Aging Clin. Exp. Res.
– volume: 9
  start-page: 129
  year: 2021
  article-title: NICE guideline on long COVID
  publication-title: Lancet Respir. Med.
– volume: 4
  year: 2022
  article-title: Rapid vigilance and episodic memory decrements in COVID‐19 survivors
  publication-title: Brain Commun.
– volume: 28
  start-page: 331
  year: 2021
  end-page: 342.e5
  article-title: ApoE‐isoform‐dependent SARS‐CoV‐2 neurotropism and cellular response
  publication-title: Cell Stem Cell
– volume: 8
  year: 2021
  article-title: Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID‐19: Systematic review and meta‐synthesis
  publication-title: Neurol. Neuroimmunol. Neuroinflammation
– volume: 75
  start-page: 24
  year: 2021
  end-page: 25
  article-title: Novel brief screening scale, Tokyo Metropolitan Distress Scale for Pandemic (TMDP), for assessing mental and social stress of medical personnel in COVID‐19 pandemic
  publication-title: Psychiatry Clin. Neurosci.
– volume: 57
  year: 2021
  article-title: The high mental health burden of “Long COVID” and its association with on‐going physical and respiratory symptoms in all adults discharged from hospital
  publication-title: Eur. Respir. J.
– volume: 131
  year: 2021
  article-title: Interleukin‐6 as potential mediator of long‐term neuropsychiatric symptoms of COVID‐19
  publication-title: Psychoneuroendocrinology
– volume: 12
  start-page: 2239
  year: 2021
  article-title: Use of transcutaneous auricular vagus nerve stimulation as an adjuvant therapy for the depressive symptoms of COVID‐19: A literature review
  publication-title: Front. Psychiatry
– volume: 37
  start-page: 1943
  year: 2022
  end-page: 1952
  article-title: Post‐COVID‐19 syndrome in outpatients: A cohort study
  publication-title: J. Gen. Intern. Med.
– year: 2021
– volume: 4
  year: 2021
  article-title: Persistent neuropsychiatric symptoms after COVID‐19: A systematic review and meta‐analysis
  publication-title: Brain Commun.
– volume: 269
  start-page: 3400
  year: 2022
  end-page: 3412
  article-title: Cognitive, EEG, and MRI features of COVID‐19 survivors: A 10‐month study
  publication-title: J. Neurol.
– volume: 309
  start-page: 309
  year: 2022
  end-page: 312
  article-title: Multimorbidity associated with anxiety symptomatology in post‐COVID patients
  publication-title: Psychiatry Res.
– volume: 77
  start-page: 683
  year: 2020
  end-page: 690
  article-title: Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
  publication-title: JAMA Neurol.
– volume: 18
  start-page: 100387
  year: 2021
  article-title: Brain correlates of depression, post‐traumatic distress, and inflammatory biomarkers in COVID‐19 survivors: A multimodal magnetic resonance imaging study
  publication-title: Brain Behav. Immun. Health
– volume: 49
  start-page: 3197
  year: 2022
  end-page: 3202
  article-title: Visual interpretation of brain hypometabolism related to neurological long COVID: A French multicentric experience
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
– volume: 397
  start-page: 220
  year: 2021
  end-page: 232
  article-title: 6‐month consequences of COVID‐19 in patients discharged from hospital: A cohort study
  publication-title: Lancet
– volume: 11
  start-page: 1203
  year: 2021
  article-title: Sleep dysfunction in COVID‐19 patients: Prevalence, risk factors, mechanisms, and management
  publication-title: J. Pers. Med.
– volume: 23
  start-page: 25
  year: 2021
  article-title: Neuropsychiatric complications of COVID‐19
  publication-title: Curr. Psychiatry Rep.
– volume: 29
  start-page: 1218
  year: 2022
  end-page: 1221
  article-title: Cognitive sequelae of long COVID may not be permanent: A prospective study
  publication-title: Eur. J. Neurol.
– volume: 42
  start-page: 804
  year: 2022
  end-page: 809
  article-title: Post‐COVID‐19 persistent headache: A multicentric 9‐months follow‐up study of 905 patients
  publication-title: Cephalalgia
– volume: 62
  start-page: 910
  year: 2021
  end-page: 915
  article-title: Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID‐19 patients
  publication-title: J. Nucl. Med.
– volume: 46
  start-page: 39
  year: 2021
  end-page: 48
  article-title: Cognitive impairments four months after COVID‐19 hospital discharge: Pattern, severity and association with illness variables
  publication-title: Eur. Neuropsychopharmacol.
– volume: 63
  start-page: 1058
  year: 2022
  end-page: 1063
  article-title: Neuropsychological profiles and cerebral glucose metabolism in neurocognitive long COVID‐syndrome
  publication-title: J. Nucl. Med.
– volume: 117
  year: 2021
  article-title: The COVID‐19 outbreak and PNES: The impact of a ubiquitously felt stressor
  publication-title: Epilepsy Behav.
– volume: 20
  start-page: 1
  year: 2022
  end-page: 10
  article-title: Long COVID 12 months after discharge: Persistent symptoms in patients hospitalised due to COVID‐19 and patients hospitalised due to other causes – A multicentre cohort study
  publication-title: BMC Med.
– volume: 30
  year: 2021
– volume: 9
  start-page: 1
  year: 2022
  end-page: 18
  article-title: Management of post‐COVID‐19 olfactory dysfunction
  publication-title: Curr. Treat. Options Allergy
– volume: 11
  start-page: 16144
  year: 2021
  article-title: More than 50 long‐term effects of COVID‐19: A systematic review and meta‐analysis
  publication-title: Sci. Rep.
– volume: 51
  start-page: 1107
  year: 2021
  end-page: 1120
  article-title: Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19
  publication-title: Clin. Exp. Allergy
– volume: 49
  start-page: 913
  year: 2022
  end-page: 920
  article-title: Similar patterns of [ F]‐FDG brain PET hypometabolism in paediatric and adult patients with long COVID: A paediatric case series
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
– volume: 56
  start-page: 29
  year: 2022
  end-page: 41
  article-title: Abnormality pattern of F‐18 FDG PET whole body with functional MRI brain in post‐acute COVID‐19
  publication-title: Nucl. Med. Mol. Imaging
– volume: 18
  year: 2021
  article-title: Early experiences of rehabilitation for individuals post‐COVID to improve fatigue, breathlessness exercise capacity and cognition – A cohort study
  publication-title: Chron. Respir. Dis.
– year: 2022
  article-title: Cognitive processing therapy for posttraumatic stress disorder due to COVID‐19‐related traumas: A case study
  publication-title: Psychol. Serv.
– volume: 2
  year: 2022
– volume: 122
  start-page: 465
  year: 2022
  end-page: 469
  article-title: Indomethacin for refractory COVID or post‐COVID headache: A retrospective study
  publication-title: Acta Neurol. Belg.
– volume: 28
  start-page: 1461
  year: 2022
  end-page: 1467
  article-title: Long COVID after breakthrough SARS‐CoV‐2 infection
  publication-title: Nat. Med.
– volume: 38
  start-page: 101019
  year: 2021
  article-title: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
  publication-title: eClinicalMedicine
– volume: 181
  start-page: 1597
  year: 2022
  end-page: 1607
  article-title: Long COVID symptoms and duration in SARS‐CoV‐2 positive children – A nationwide cohort study
  publication-title: Eur. J. Pediatr.
– start-page: 1
  year: 2022
  end-page: 5
– start-page: 1
  year: 2022
  end-page: 2
  article-title: Trajectory curves of post‐COVID anxiety/depressive symptoms and sleep quality in previously hospitalized COVID‐19 survivors: The long‐COVID‐EXP‐CM multicenter study
  publication-title: Psychol. Med.
– volume: 9
  start-page: 815
  year: 2022
  end-page: 827
  article-title: Neurological and psychiatric risk trajectories after SARS‐CoV‐2 infection: An analysis of 2‐year retrospective cohort studies including 1 284 437 patients
  publication-title: Lancet Psychiatry
– volume: 19
  start-page: 919
  year: 2020
  end-page: 929
  article-title: Neuropathology of patients with COVID‐19 in Germany: A post‐mortem case series
  publication-title: Lancet Neurol.
– volume: 19
  start-page: 2290
  year: 2022
  article-title: Functional and psychological changes after exercise training in post‐COVID‐19 patients discharged from the hospital: A PRISMA‐compliant systematic review
  publication-title: Int. J. Environ. Res. Public Health
– volume: 36
  start-page: 582
  year: 2022
  end-page: 584
  article-title: Preexisting hypertension is associated with a greater number of long‐term post‐COVID symptoms and poor sleep quality: A case–control study
  publication-title: J. Hum. Hypertens.
– volume: 2
  start-page: 1
  year: 2021
  end-page: 13
  article-title: Cardiovascular abnormalities and mental health difficulties result in a reduced quality of life in the post‐acute COVID‐19 syndrome
  publication-title: Brain Sci.
– volume: 91
  start-page: 150
  year: 2022
  end-page: 157
  article-title: Cerebrospinal fluid analysis post‐COVID‐19 is not suggestive of persistent central nervous system infection
  publication-title: Ann. Neurol.
– volume: 22
  start-page: 77
  year: 2022
  article-title: Self‐reported olfactory and gustatory dysfunctions in COVID‐19 patients: A 1‐year follow‐up study in Foggia district, Italy
  publication-title: BMC Infect. Dis.
– volume: 144
  start-page: 129
  year: 2021
  article-title: Onset and frequency of depression in post‐COVID‐19 syndrome: A systematic review
  publication-title: J. Psychiatr. Res.
– volume: 328
  start-page: 676
  year: 2022
  end-page: 678
  article-title: Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers
  publication-title: JAMA
– volume: 12
  start-page: 265
  year: 2022
  article-title: Examining association of personality characteristics and neuropsychiatric symptoms in post‐COVID syndrome
  publication-title: Brain Sci.
– volume: 4
  start-page: 1
  year: 2022
  end-page: 8
  article-title: Exposure to phenytoin associates with a lower risk of post‐COVID cognitive deficits: A cohort study
  publication-title: Brain Commun.
– volume: 48
  start-page: 3187
  year: 2021
  end-page: 3197
  article-title: Long COVID hallmarks on [ F] FDG‐PET/CT: A case–control study
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
– volume: 398
  start-page: 747
  year: 2021
  end-page: 758
  article-title: 1‐year outcomes in hospital survivors with COVID‐19: A longitudinal cohort study
  publication-title: Lancet
– year: 2022
  article-title: Mild respiratory SARS‐CoV‐2 infection can cause multi‐lineage cellular dysregulation and myelin loss in the brain
  publication-title: bioRxiv
– volume: 8
  start-page: 416
  year: 2021
  end-page: 427
  article-title: 6‐month neurological and psychiatric outcomes in 236 379 survivors of COVID‐19: A retrospective cohort study using electronic health records
  publication-title: Lancet Psychiatry
– volume: 305
  start-page: 114243
  year: 2021
  article-title: Long term impact of Covid‐19 infection on sleep and mental health: A cross‐sectional study
  publication-title: Psychiatry Res.
– volume: 29
  start-page: 2006
  year: 2022
  end-page: 2014
  article-title: One‐year cognitive follow‐up of COVID‐19 hospitalized patients
  publication-title: Eur. J. Neurol.
– volume: 11
  year: 2022
  article-title: Psychological symptoms in COVID‐19 patients: Insights into pathophysiology and risk factors of long COVID‐19
  publication-title: Biology (Basel)
– volume: 479
  start-page: 537
  year: 2022
  end-page: 559
  article-title: A central role for amyloid fibrin microclots in long COVID/PASC: Origins and therapeutic implications
  publication-title: Biochem. J.
– volume: 64
  year: 2021
  article-title: Fatigue, perceived stigma, self‐reported cognitive deficits and psychological morbidity in patients recovered from COVID‐19 infection
  publication-title: Asian J. Psychiatr.
– volume: 84
  start-page: 566
  year: 2022
  end-page: 572
  article-title: Determinants of persistence of symptoms and impact on physical and mental wellbeing in long COVID: A prospective cohort study
  publication-title: J. Infect.
– volume: 89
  start-page: 531
  year: 2020
  end-page: 542
  article-title: COVID‐19 pandemic and mental health consequences: Systematic review of the current evidence
  publication-title: Brain Behav. Immun.
– volume: 10
  start-page: 4337
  year: 2021
  article-title: Severe fatigue and memory impairment are associated with lower serum level of Anti‐SARS‐CoV‐2 antibodies in patients with post‐COVID symptoms
  publication-title: J. Clin. Med.
– volume: 125
  year: 2021
  article-title: Risk factors for psychological distress in electroencephalography technicians during the COVID‐19 pandemic: A national‐level cross‐sectional survey in Japan
  publication-title: Epilepsy Behav.
– volume: 18
  start-page: 1047
  year: 2022
  end-page: 1066
  article-title: Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysis
  publication-title: Alzheimers Dement.
– volume: 50
  start-page: 661
  year: 2022
  end-page: 669
  article-title: Comparison of fatigue, cognitive dysfunction and psychological disorders in post‐COVID patients and patients after sepsis: Is there a specific constellation?
  publication-title: Infection
– volume: 15
  start-page: 107
  year: 2015
  article-title: Relationship between the Montreal Cognitive Assessment and Mini‐mental State Examination for assessment of mild cognitive impairment in older adults
  publication-title: BMC Geriatr.
– volume: 83
  start-page: 504
  year: 2021
  end-page: 506
  article-title: Anxiety, depression and poor sleep quality as long‐term post‐COVID sequelae in previously hospitalized patients: A multicenter study
  publication-title: J. Infect.
– ident: e_1_2_13_32_1
– ident: e_1_2_13_60_1
  doi: 10.1111/ene.15324
– ident: e_1_2_13_122_1
  doi: 10.1007/s00431-021-04345-z
– ident: e_1_2_13_15_1
  doi: 10.1016/S2215-0366(20)30462-4
– ident: e_1_2_13_21_1
  doi: 10.1097/PHM.0000000000001910
– ident: e_1_2_13_138_1
  doi: 10.1038/s41591-022-01840-0
– ident: e_1_2_13_77_1
  doi: 10.1007/s00415-021-10655-x
– ident: e_1_2_13_92_1
  doi: 10.1016/j.psyneuen.2021.105295
– ident: e_1_2_13_5_1
– volume: 83
  start-page: 504
  year: 2021
  ident: e_1_2_13_25_1
  article-title: Anxiety, depression and poor sleep quality as long‐term post‐COVID sequelae in previously hospitalized patients: A multicenter study
  publication-title: J. Infect.
– ident: e_1_2_13_99_1
  doi: 10.1186/s40478-021-01302-7
– ident: e_1_2_13_20_1
  doi: 10.1016/j.eclinm.2021.101019
– ident: e_1_2_13_83_1
  doi: 10.2967/jnumed.121.262128
– ident: e_1_2_13_23_1
  doi: 10.1093/ofid/ofab384
– ident: e_1_2_13_42_1
  doi: 10.1016/j.jpsychires.2021.09.054
– ident: e_1_2_13_126_1
  doi: 10.4103/0972-6748.328787
– ident: e_1_2_13_6_1
– ident: e_1_2_13_114_1
  doi: 10.1007/s40520-021-02042-3
– ident: e_1_2_13_108_1
  doi: 10.1177/03331024211020404
– ident: e_1_2_13_49_1
  doi: 10.1016/j.psychres.2021.114243
– ident: e_1_2_13_123_1
  doi: 10.1186/s12879-022-07052-8
– ident: e_1_2_13_33_1
– ident: e_1_2_13_98_1
  doi: 10.1038/s41586-020-2247-3
– ident: e_1_2_13_105_1
  doi: 10.1007/s10072-021-05786-y
– ident: e_1_2_13_116_1
  doi: 10.1016/j.psychres.2022.114427
– ident: e_1_2_13_62_1
  doi: 10.1016/j.yebeh.2021.108361
– volume: 9
  start-page: CD013877
  year: 2022
  ident: e_1_2_13_128_1
  article-title: Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction
  publication-title: Cochrane Database Syst. Rev.
– ident: e_1_2_13_106_1
  doi: 10.1111/cea.13997
– ident: e_1_2_13_136_1
  doi: 10.3389/fpsyt.2021.765106
– ident: e_1_2_13_3_1
– ident: e_1_2_13_37_1
  doi: 10.1093/braincomms/fcaa205
– ident: e_1_2_13_96_1
  doi: 10.1042/BCJ20220016
– ident: e_1_2_13_4_1
  doi: 10.1001/jamaneurol.2020.1127
– ident: e_1_2_13_9_1
  doi: 10.1093/braincomms/fcab297
– ident: e_1_2_13_85_1
  doi: 10.2967/jnumed.121.263085
– ident: e_1_2_13_19_1
  doi: 10.1016/S0140-6736(20)32656-8
– ident: e_1_2_13_55_1
  doi: 10.1007/s10072-021-05630-3
– ident: e_1_2_13_111_1
  doi: 10.1038/s41371-022-00660-6
– ident: e_1_2_13_18_1
– ident: e_1_2_13_91_1
  doi: 10.1017/cjn.2021.256
– ident: e_1_2_13_124_1
  doi: 10.1111/ene.15307
– ident: e_1_2_13_35_1
  doi: 10.1007/s00415-022-11047-5
– ident: e_1_2_13_50_1
  doi: 10.1016/j.ajp.2021.102815
– ident: e_1_2_13_71_1
  doi: 10.1016/j.yebeh.2020.107682
– ident: e_1_2_13_107_1
  doi: 10.3389/fnhum.2021.678472
– ident: e_1_2_13_137_1
  doi: 10.1001/jama.2022.11691
– ident: e_1_2_13_14_1
  doi: 10.1007/s11606-021-07242-1
– ident: e_1_2_13_48_1
  doi: 10.1101/2021.04.15.21255348
– ident: e_1_2_13_30_1
  doi: 10.1007/s11356-021-18384-4
– volume: 10
  start-page: 1
  year: 2021
  ident: e_1_2_13_95_1
  article-title: Characterization and biomarker analyses of post‐COVID‐19 complications and neurological manifestations
  publication-title: Cell
– ident: e_1_2_13_78_1
– ident: e_1_2_13_88_1
  doi: 10.1002/mds.28084
– ident: e_1_2_13_125_1
  doi: 10.1177/14799731211015691
– ident: e_1_2_13_22_1
  doi: 10.1212/WNL.0000000000200356
– ident: e_1_2_13_81_1
  doi: 10.1007/s00259-021-05528-4
– ident: e_1_2_13_24_1
– ident: e_1_2_13_100_1
  doi: 10.1016/j.yebeh.2021.107852
– ident: e_1_2_13_10_1
– ident: e_1_2_13_87_1
  doi: 10.1016/j.bbi.2020.03.031
– ident: e_1_2_13_16_1
  doi: 10.1007/s15010-021-01733-3
– volume: 56
  start-page: 2372
  year: 2020
  ident: e_1_2_13_29_1
  article-title: Impact of cough on insomnia and sleep quality in bronchiectasis
  publication-title: Eur. Respir. J.
– ident: e_1_2_13_115_1
  doi: 10.3390/brainsci12020265
– ident: e_1_2_13_117_1
  doi: 10.1016/S2215-0366(21)00084-5
– ident: e_1_2_13_110_1
  doi: 10.1111/ijcp.14917
– ident: e_1_2_13_119_1
  doi: 10.1017/S003329172200006X
– ident: e_1_2_13_43_1
  doi: 10.2196/33704
– volume: 20
  start-page: 1
  year: 2022
  ident: e_1_2_13_44_1
  article-title: Long COVID 12 months after discharge: Persistent symptoms in patients hospitalised due to COVID‐19 and patients hospitalised due to other causes – A multicentre cohort study
  publication-title: BMC Med.
– ident: e_1_2_13_84_1
  doi: 10.1007/s00259-021-05342-y
– ident: e_1_2_13_56_1
  doi: 10.1093/arclin/acac004
– ident: e_1_2_13_63_1
  doi: 10.1016/j.bbi.2021.12.020
– ident: e_1_2_13_47_1
  doi: 10.1016/j.genhosppsych.2022.01.002
– ident: e_1_2_13_64_1
  doi: 10.1136/jim-2021-002051
– ident: e_1_2_13_45_1
  doi: 10.1080/20008198.2021.1959707
– ident: e_1_2_13_102_1
  doi: 10.3390/jcm11061541
– ident: e_1_2_13_76_1
  doi: 10.1016/j.neurad.2022.03.003
– ident: e_1_2_13_58_1
  doi: 10.1186/s12877-015-0103-3
– ident: e_1_2_13_26_1
  doi: 10.1097/CCM.0000000000005476
– ident: e_1_2_13_27_1
  doi: 10.3390/jpm11111203
– ident: e_1_2_13_113_1
  doi: 10.1016/j.jns.2022.120146
– ident: e_1_2_13_66_1
  doi: 10.1080/03007995.2022.2042991
– ident: e_1_2_13_101_1
  doi: 10.1016/j.bbi.2020.05.048
– ident: e_1_2_13_134_1
  doi: 10.3390/ph15030345
– ident: e_1_2_13_11_1
– ident: e_1_2_13_69_1
  doi: 10.1177/20499361211048572
– ident: e_1_2_13_118_1
– ident: e_1_2_13_7_1
  doi: 10.1007/s11920-021-01237-9
– ident: e_1_2_13_40_1
  doi: 10.1111/ene.15215
– ident: e_1_2_13_112_1
  doi: 10.3389/fpsyt.2021.725861
– ident: e_1_2_13_38_1
  doi: 10.1002/brb3.2508
– ident: e_1_2_13_13_1
  doi: 10.1016/S2215-0366(22)00260-7
– ident: e_1_2_13_132_1
  doi: 10.3390/ijerph19042290
– ident: e_1_2_13_2_1
  doi: 10.1056/NEJMoa2002032
– ident: e_1_2_13_79_1
  doi: 10.1007/s00259-021-05215-4
– ident: e_1_2_13_130_1
  doi: 10.1037/ser0000630
– ident: e_1_2_13_68_1
  doi: 10.1101/2022.01.07.475453
– ident: e_1_2_13_93_1
  doi: 10.1016/S1474-4422(20)30308-2
– volume: 11
  year: 2022
  ident: e_1_2_13_89_1
  article-title: Psychological symptoms in COVID‐19 patients: Insights into pathophysiology and risk factors of long COVID‐19
  publication-title: Biology (Basel)
– ident: e_1_2_13_97_1
  doi: 10.1097/XCE.0000000000000253
– ident: e_1_2_13_36_1
  doi: 10.1016/j.euroneuro.2021.03.019
– ident: e_1_2_13_67_1
  doi: 10.3390/jcm10194337
– ident: e_1_2_13_94_1
  doi: 10.1016/j.stem.2020.12.018
– ident: e_1_2_13_82_1
  doi: 10.1007/s00259-021-05294-3
– ident: e_1_2_13_51_1
– ident: e_1_2_13_109_1
  doi: 10.1002/jmv.27397
– ident: e_1_2_13_41_1
  doi: 10.1093/braincomms/fcab295
– ident: e_1_2_13_127_1
  doi: 10.1007/s13760-021-01790-3
– ident: e_1_2_13_70_1
  doi: 10.1002/ana.26262
– ident: e_1_2_13_34_1
  doi: 10.3389/fpsyg.2022.770459
– ident: e_1_2_13_72_1
  doi: 10.1016/j.jns.2020.117271
– ident: e_1_2_13_61_1
  doi: 10.1111/pcn.13168
– ident: e_1_2_13_120_1
  doi: 10.1016/j.bbi.2021.07.018
– ident: e_1_2_13_131_1
  doi: 10.1093/braincomms/fcac206
– ident: e_1_2_13_104_1
  doi: 10.1016/j.jinf.2022.02.003
– ident: e_1_2_13_135_1
  doi: 10.1002/prp2.911
– ident: e_1_2_13_39_1
  doi: 10.1016/j.bbih.2021.100347
– ident: e_1_2_13_52_1
  doi: 10.1016/j.psychres.2020.113312
– ident: e_1_2_13_73_1
– ident: e_1_2_13_103_1
  doi: 10.1016/S0140-6736(21)01755-4
– ident: e_1_2_13_54_1
  doi: 10.2967/jnumed.121.262677
– ident: e_1_2_13_65_1
  doi: 10.1002/acn3.51496
– ident: e_1_2_13_57_1
  doi: 10.1080/13854046.2022.2030412
– ident: e_1_2_13_31_1
  doi: 10.1002/alz.12644
– ident: e_1_2_13_46_1
  doi: 10.1183/13993003.04364-2020
– ident: e_1_2_13_90_1
  doi: 10.1212/NXI.0000000000001080
– ident: e_1_2_13_12_1
  doi: 10.1016/S2213-2600(21)00031-X
– ident: e_1_2_13_8_1
  doi: 10.1038/s41598-021-95565-8
– ident: e_1_2_13_121_1
  doi: 10.1177/03331024211068074
– ident: e_1_2_13_74_1
  doi: 10.1007/s13139-021-00730-6
– ident: e_1_2_13_86_1
– volume: 2
  start-page: 1
  year: 2021
  ident: e_1_2_13_59_1
  article-title: Cardiovascular abnormalities and mental health difficulties result in a reduced quality of life in the post‐acute COVID‐19 syndrome
  publication-title: Brain Sci.
– ident: e_1_2_13_129_1
  doi: 10.1007/s40521-021-00297-9
– ident: e_1_2_13_80_1
  doi: 10.1007/s00259-022-05753-5
– ident: e_1_2_13_75_1
  doi: 10.1016/j.bbih.2021.100387
– volume: 63
  start-page: 474
  year: 2022
  ident: e_1_2_13_53_1
  article-title: Neuropsychological, medical, and psychiatric findings after recovery from acute COVID‐19: A cross‐sectional study
  publication-title: J. Acad. Consult. Psychiatry
– ident: e_1_2_13_133_1
  doi: 10.1016/j.amjoto.2020.102884
– ident: e_1_2_13_17_1
  doi: 10.1016/S0140-6736(22)00941-2
– ident: e_1_2_13_28_1
  doi: 10.1007/s00408-009-9176-0
SSID ssj0003361
Score 2.6076953
SecondaryResourceType review_article
Snippet Although some patients have persistent symptoms or develop new symptoms following coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of...
Although some patients have persistent symptoms or develop new symptoms following coronavirus disease 2019 (COVID-19) infection, neuropsychiatric aspects of...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 84
SubjectTerms Anxiety Disorders
Cognitive ability
Coronaviruses
COVID-19
Drug therapy
Environmental changes
Humans
Infections
Ischemia
Long COVID
Medical treatment
Mental disorders
neurology
PCN Frontier Review
PCN Frontier Reviews
Positron emission tomography
post COVID‐19 condition
Post-Acute COVID-19 Syndrome
psychiatry
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Sleep disorders
Vaccination
Title Neuropsychiatric aspects of long COVID: A comprehensive review
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpcn.13508
https://www.ncbi.nlm.nih.gov/pubmed/36385449
https://www.proquest.com/docview/2773524714
https://www.proquest.com/docview/2737466835
https://pubmed.ncbi.nlm.nih.gov/PMC10108156
Volume 77
WOSCitedRecordID wos000896704600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 1440-1819
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0003361
  issn: 1323-1316
  databaseCode: WIN
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1440-1819
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0003361
  issn: 1323-1316
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS-QwEB9E5biX87zz7qqe5MQHXwpNkzTZOxBkdVHQdRE_9q2kaXK7IF3ZVf9-J2m3uHjCgS-lJVOaZjozv2nmA2CvFK7sqNKim-pYzFMtY51oGgsni0SjXjRJSBQ-k_2-Gg47gyX4M8-FqetDtD_cvGQEfe0FXBezF0J-byrftMEn-q5QypTv25DyQauGGcsab4vFlNGsKSvkw3jaWxeN0SuE-TpQ8iWADRaot_auuX-GTw3wJIf1l7IOS7b6Ah_Om631r3AQynS0wc9jQ3TIwpyRiSN3k-ov6V7cnB79JofEh6FP7agOfSd18ssGXPWOr7oncdNcITaCcRUXpc0stZolThXUoQFDIJjoUjCtMqUzWmRKSvTmkHUK2cyFRNeISpe4pEgF-wbL1aSyP4BoY0p0qpwxsuQG_Q-DIEx6aUcsIFIRwf58kXPTFB73_S_u8rkDgsuRh-WIYLclva-rbfyLaHvOqbwRuFmeSolQEi0tj-BXO4yi4vc_dGUnj56GSZ5liDkj-F4ztn0KQz0kOO9EoBZY3hL4MtyLI9V4FMpxo1JLfM0dfM_A87dnng-6_XCy-f-kW_AxDR04fNjbNiw_TB_tT1g1Tw_j2XQnfPJ4lEO1AytHl73rM7y6Pe0_A6L8BhQ
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED-hMgEvsA8-Ah14aA-8REpqO3anaRIqQ1QrgYeK9S1yHBsqoRS1lL-fs5NGVGwSEm-RfFEcn-_ud_Z9AHwvuC26sjDoploaso4SoYpUHHIr8kihXtSRTxQeiDSVo1H3egV-LnJhqvoQzYGbkwyvr52AuwPpF1L-oEvXtcFl-q4yBBquccPfftroYUqT2t2iYUzjpK4r5OJ4mleXrdEriPk6UvIlgvUm6HzrfZP_CJs19CSn1V75BCum_Axrl_Xl-hf45Qt1NOHPY02Uz8OckYkl95PylvSubvpnP8gpcYHoU3NXBb-TKv1lG4bnv4e9i7BurxBqTpkM88IkJjaKRlbmsUUThlAwUgWnSiZSJXGeSCHQn0PmSWQ04wKdo1jYyEZ5h9MdaJWT0uwBUVoX6FZZrUXBNHogGmGYcPKOaIB3eAAni1XOdF163HXAuM8WLgguR-aXI4DjhvShqrfxL6L2glVZLXKzrCMEgkm0tSyAb80wCou7AVGlmcwdDRUsSRB1BrBbcbb5CkVNxBnrBiCXeN4QuELcyyPl-M4X5Ea1FrmqO_ifnun_n3l23Uv9w_7bSY9g_WJ4OcgG_fTPAWy4fvdV2HgbWo_TufkKH_TT43g2PfT7_xlbrQbV
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS-QwEB9kPeRezvPjvJ4fF8UHXwrtJmmyIgey63Jy67qIim8lTZPbBekuu-rf7yTtFhcVBN8KmdI005n8ppn5DcBhzm3ekrnBMNXSkDWVCFWk4pBbkUUK_aKOfKFwT_T78u6uNViCk3ktTMkPUf9wc5bh_bUzcDPJ7Qsrn-jCdW1wlb7LzDWRacBy56p706s9MaVJFXDRMKZxUjELuUye-ubF_egVyHydK_kSw_pNqLv6uel_h28V-CSn5deyBkumWIeVi-p4fQP-eKqOOgF6pInylZgzMrbkflz8J-3L2_POMTklLhV9aoZl-jspC2A24bp7dt3-G1YNFkLNKZNhlpvExEbRyMostriJIRiMVM6pkolUSZwlUgiM6FB9ElXNuMDwKBY2slHW5PQHNIpxYX4CUVrnGFhZrUXONMYgGoGYcBaPeIA3eQBH81VOdUU-7npg3KfzIASXI_XLEcBBLTopGTfeEtqZqyqtjG6WNoVAOIm7LQtgvx5Gc3FnIKow40cnQwVLEsSdAWyVmq2fQtEXccZaAcgFndcCjop7caQYDT0lNzq2yPHu4Ht6pb8_83TQ7vuLXx8X_Q0rg0437Z33_23DV9fwvswb34HGw_TR7MIX_fQwmk33KgN4BgnSB34
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neuropsychiatric+aspects+of+long+COVID%3A+A+comprehensive+review&rft.jtitle=Psychiatry+and+clinical+neurosciences&rft.au=Kubota%2C+Takafumi&rft.au=Kuroda%2C+Naoto&rft.au=Sone%2C+Daichi&rft.date=2023-02-01&rft.eissn=1440-1819&rft.volume=77&rft.issue=2&rft.spage=84&rft_id=info:doi/10.1111%2Fpcn.13508&rft_id=info%3Apmid%2F36385449&rft.externalDocID=36385449
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1323-1316&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1323-1316&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1323-1316&client=summon